Embleema Embleema (RWE)

Description:

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs. Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators. The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema's blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.

Category: ❖Drugs & Healthcare
Hype:  
Rating: 8.8/10
Project Type: Blochchain
Platform: Ethereum
Location: France
Total Supply: 150,000,000
Soft Cap: 2,000,000 USD
Hard Cap: 30,000,000 USD
ICO Price: 1 RWE = 0.2 USD
Accepting Currency: BTC, ETH, BCH, Fiat
Restricted Countries: USA, Canada, China, Iran, Sudan, Syria, North Korea, Crimea, New Zealand, Cuba
KYC: Yes
Whitelist: No

Start Date

May 12th 2019 08:19 UTC

Days Hours Minutes Seconds

End Date

May 12th 2019 08:19 UTC

Days Hours Minutes Seconds

Team

Robert Chu

CEO and CTO, former head of IMS / IQVIA in France & China, SVP of Technology Solutions

Alexis Normand

Head of Embleema Consortium, former Head of B2B Nokia Digital health / Withings

Pradeep Sreekanthan

Chief Delivery Officer, Former Director at IMS Health

Prashant Khambekar, Ph.D

Chief Development Executive, SVP Harbringer Systems

Nicolas Schmidt

Chief Product Officer, former head of Healthcare Products at Nokia

Vincent Galand

Operations Manager France

Lorenzo Nardiello

Social Media Manager

Xavier Lavayssière

Blockchain Regulation and Smart Contracts Expert

Munair Simpson

ICO & Crypto Expert - Asia

Advisers

Dr. Vahan Simonyan

Pr. John Halamka, MD

Bernard Gilly, PhD

Frédéric Duchesne, Pharm.D

Adel B. Al-Saleh

steemit